Evidence map›Paper›PMID 38005990›Full record

ReviewVaccines2023

Advancing Vaccine Strategies against

Gurpreet Kaur, Sonam Chawla, Piyush Kumar, Ritu Singh

Open access · goldAbstract readReview
In one paragraph

Review in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. The pathogenicity and future treatment strategies ofFrontiers in cellular and infection microbiology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. [Molecular Epidemiology and Fluconazole Resistance Mechanisms inSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  9. A Comprehensive Overview ofJournal of fungi (Basel, Switzerland) · 2025
    Review
  10. Article
  11. Innovative antifungal strategies to combat drug-resistantFrontiers in cellular and infection microbiology · 2025
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gurpreet KaurDepartment of Biotechnology, Chandigarh College of Technology (CCT), Chandigarh Group of Colleges (CGC), Landran, Mohali 140307, India.ORCID 0000-0002-9605-5502
Sonam ChawlaDepartment of Biotechnology, Jaypee Institute of Information Technology, Sector 62, Noida 201309, India.ORCID 0000-0002-6187-4778
Piyush KumarDepartment of Biotechnology, Jaypee Institute of Information Technology, Sector 62, Noida 201309, India.ORCID 0009-0000-9140-6898
Ritu SinghDepartment of Biotechnology, Jaypee Institute of Information Technology, Sector 62, Noida 201309, India.ORCID 0009-0008-5950-2888
Jaypee Institute of Information Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antifungal vaccinesCandidacandidiasis preventionfungal immunityopportunistic infectionstherapeutic innovations

Identifiers

PMID38005990
PMCPMC10674196
OpenAlexW4388443534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.